Why Are Zogenix's Shares Gaining Today?
The FDA has granted Priority Review to Zogenix Inc's (NASDAQ:ZGNX) supplemental marketing application seeking approval for Fintepla (fenfluramine) in Lennox-Gastaut syndrome (LGS) childhood-onset epilepsy.
The agency's Prescription Drug…